Yin Anthony, Alfadhli Eman, Htun Michelle, Dudley Robert, Faulkner Sandra, Hull Laura, Leung Andrew, Bross Rachelle, Longstreth James, Swerdloff Ronald, Wang Christina
Division of Endocrinology, Department of Medicine and the UCLA–Clinical and Translational Science Institute, Harbor-UCLA Medical Center and Los Angeles Biomedical Research Institute, Torrance, California 90509, USA.
J Androl. 2012 Nov-Dec;33(6):1282-90. doi: 10.2164/jandrol.112.017020. Epub 2012 Jul 12.
This study investigates the effect of dietary fat on the testosterone (T) pharmacokinetics in hypogonadal men following administration of a self-emulsifying capsule formulation of oral T undecanoate (TU). In an open-label, 2-center, 5-way crossover study, a single oral dose of TU containing 300-mg equivalents of T (maximum anticipated human dose per administration) was administered to 16 hypogonadal men with a washout period of at least 5 days between doses. All participants were randomized to receive the TU capsules fasting or 30 minutes after an approximately 800-calorie meal containing 10%, 20%, 30%, or 50% fat. Serial blood samples were collected from 2 hours predose to 25 hours postdose to determine serum T and dihydrotestosterone (DHT) by liquid chromatography tandem mass spectrometry. Administering TU with a meal increased serum T concentrations, with the magnitude of the increase being directly dependent on the amount of fat in the meal. Average and peak serum T concentrations and area under the curve increased as the fat content of the meal was increased. Neither the high-fat meal (50% fat) nor the lower-fat meal (20% fat) showed a significant food effect relative to the normal-fat (Western diet) meal (30% fat). However, administering TU while fasting resulted in 50% or less of the cumulative exposure obtained when administered with 20%- to 50%-fat meals (albeit still substantial). A very-low-fat meal (10% fat) showed a significant food effect relative to the normal meal, but still exceeded the fasting condition by approximately 50%. Serum DHT concentrations showed corresponding increases to the serum T. As expected with the maximum anticipated clinical dose of TU (300 mg T), oral administration of this new formulation with food containing 20% to 50% dietary fat produced T levels at or above the upper range of adult men, and T levels trended higher as dietary fat content increased. Only with a very-low-fat diet (10%) or in a fasted state did a clinically significant food effect occur, but even then sufficient TU was absorbed with the self-emulsifying TU formulation to produce average serum T concentration predicted to be in the normal reference range (10 to 35 nmol/L).
本研究调查了饮食脂肪对性腺功能减退男性口服十一酸睾酮(TU)自乳化胶囊制剂后睾酮(T)药代动力学的影响。在一项开放标签、2中心、5交叉试验中,对16名性腺功能减退男性单次口服含300毫克当量T(每次给药的最大预期人体剂量)的TU,给药间隔至少5天的洗脱期。所有参与者被随机分组,在空腹或进食约含10%、20%、30%或50%脂肪的800卡路里餐食后30分钟接受TU胶囊。在给药前2小时至给药后25小时采集系列血样,采用液相色谱串联质谱法测定血清T和双氢睾酮(DHT)。进食时服用TU会增加血清T浓度,增加幅度直接取决于餐食中的脂肪量。随着餐食脂肪含量增加,血清T的平均浓度、峰值浓度及曲线下面积均增加。高脂肪餐(50%脂肪)和低脂肪餐(20%脂肪)相对于正常脂肪(西方饮食)餐(30%脂肪)均未显示出显著的食物效应。然而,空腹服用TU导致的累积暴露量仅为与含20%至50%脂肪餐食一起服用时的50%或更低(尽管仍相当可观)。极低脂肪餐(10%脂肪)相对于正常餐显示出显著的食物效应,但仍比空腹状态高出约50%。血清DHT浓度与血清T相应增加。正如TU最大预期临床剂量(300毫克T)所预期的那样,口服这种新制剂并与含20%至50%膳食脂肪的食物一起服用时,产生的T水平达到或高于成年男性的上限范围,且T水平随着膳食脂肪含量增加而呈上升趋势。只有在极低脂肪饮食(10%)或禁食状态下才出现具有临床意义的食物效应,但即便如此,自乳化TU制剂仍能吸收足够的TU,使血清T平均浓度预计处于正常参考范围(10至35纳摩尔/升)。